Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASTA-DIVA: Rivaroxaban vs Dalteparin in Cancer-Associated Thrombosis
NCT02746185Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in venous thromboembolism (VTE), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2016; status: completed.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02746185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746185.